Malaria vaccine efficacy: Overcoming the helminth hurdle

Expert Review of Vaccines

Volumn 9, Issue 7, 2010, Pages 707-711

  Cruz Chan, Julio Vladimir ^a   Rosado Vallado, Miguel ^a   Dumonteil, Eric ^a  

^a UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

Author keywords

immunosuppression; intestinal parasites; Plasmodium; vaccine

Indexed keywords

ANTIBODY; CIRCUMSPOROZOITE PROTEIN; DNA VACCINE; IMMUNOGLOBULIN G; MALARIA VACCINE; PLASMODIUM FALCIPARUM SPOROZOITE ANTIGEN; SPOROZOITE VACCINE; UNCLASSIFIED DRUG;

DNA IMMUNIZATION; DRUG DESIGN; DRUG EFFICACY; HELIGMOSOMOIDES POLYGYRUS; HELIGMOSOMOIDES POLYGYRUS INFECTION; HELMINTH; HELMINTHIASIS; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTION PREVENTION; IRRADIATION; MALARIA; MALARIA FALCIPARUM; MEMORY CELL; NEMATODIASIS; NONHUMAN; NOTE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SPOROZOITE;

EID: 77954663036     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.10.63     Document Type: Note

References (45)

1. WHO. World Malaria Report. WHO, Geneva, Switzerland (2009).
2. Vekemans J, Ballou WR. Plasmodium falciparum malaria vaccines in development. Expert Rev. Vaccines 7(2), 223-240 (2008).
3. Mlambo G, Maciel J, Kumar N. Murine model for assessment of Plasmodium falciparum transmission-blocking vaccine using transgenic Plasmodium berghei parasites expressing the target antigen Pfs25. Infect. Immun. 76(5), 2018-2024 (2008).
4. Lobo CA, Dhar R, Kumar N. Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodies. Infect. Immun. 67(4), 1688-1693 (1999).
5. Vanderberg JP. Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyond. Vaccine 27(1), 2-9 (2009).
6. Hoffman SL, Billingsley PF, James E et al. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum. Vaccines 6(1), 97-106 (2010).
7. 8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330(6149), 664-666 (1987).
8. Mwangi TW, Bethony JM, Brooker S. Malaria and helminth interactions in humans: an epidemiological viewpoint. Ann. Trop. Med. Parasitol. 100(7), 551-570 (2006).
9. Turner JD, Jackson JA, Faulkner H et al. Intensity of intestinal infection with multiple worm species is related to regulatory cytokine output and immune hyporesponsiveness. J. Infect. Dis. 197(8), 1204-1212 (2008).
10. Borkow G, Bentwich Z. Chronic parasite infections cause immune changes that could affect successful vaccination. Trends Parasitol. 24(6), 243-245 (2008).
11. Markus MB, Fincham JE. Helminthiasis, bystander diseases and vaccines: analysis of interaction. Trends Parasitol. 23(11), 517-519 (2007).
12. Troye-Blomberg M, Berzins K. Immune interactions in malaria co-infections with other endemic infectious diseases: implications for the development of improved disease interventions. Microbes Infect. 10(9), 948-952 (2008).
13. Segura M, Matte C, Thawani N, Su Z, Stevenson MM. Modulation of malaria-induced immunopathology by concurrent gastrointestinal nematode infection in mice. Int. J. Parasitol. 39(14), 1525-1532 (2009).
14. Hartgers FC, Yazdanbakhsh M. Co-infection of helminths and malaria: modulation of the immune responses to malaria. Parasite Immunol. 28(10), 497-506 (2006).
15. Noland GS, Chowdhury DR, Urban JF Jr, Zavala F, Kumar N. Helminth infection impairs the immunogenicity of a Plasmodium falciparum DNA vaccine, but not irradiated sporozoites, in mice. Vaccine 28(17), 2917-2923 (2010).
16. Liu Z, Liu Q, Pesce J et al. Requirements for the development of IL-4-producing T cells during intestinal nematode infections: what it takes to make a Th2 cell in vivo. Immunol. Rev. 201, 57-74 (2004).
17. Patel N, Kreider T, Urban JF Jr, Gause WC. Characterisation of effector mechanisms at the host:parasite interface during the immune response to tissue-dwelling intestinal nematode parasites. Int. J. Parasitol. 39(1), 13-21 (2009).
18. Su Z, Segura M, Stevenson MM. Reduced protective efficacy of a blood-stage malaria vaccine by concurrent nematode infection. Infect. Immun. 74(4), 2138-2144 (2006).
19. Marshall FA, Pearce EJ. Uncoupling of induced protein processing from maturation in dendritic cells exposed to a highly antigenic preparation from a helminth parasite. J. Immunol. 181(11), 7562-7570 (2008).
20. Cooper PJ, Chico M, Sandoval C et al. Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Infect. Immun. 69(3), 1574-1580 (2001).
21. Roussilhon C, Brasseur P, Agnamey P, Perignon JL, Druilhe P. Understanding human-Plasmodium falciparum immune interactions uncovers the immunological role of worms. PLoS One 5(2), e9309 (2010).
22. Jackson JA, Friberg IM, Bolch L et al. Immunomodulatory parasites and Toll-like receptor-mediated tumour necrosis factor a responsiveness in wild mammals. BMC Biol. 7, 16 (2009).
23. Carvalho L, Sun J, Kane C et al. Review series on helminths, immune modulation and the hygiene hypothesis: mechanisms underlying helminth modulation of dendritic cell function. Immunology 126(1), 28-34 (2009).
24. Harn DA, McDonald J, Atochina O, Da'dara AA. Modulation of host immune responses by helminth glycans. Immunol. Rev. 230(1), 247-257 (2009).
25. Wammes LJ, Hamid F, Wiria AE et al. Regulatory T cells in human geohelminth infection suppress immune responses to BCG and Plasmodium falciparum. Eur. J. Immunol. 40(2), 437-442 (2010).
26. 4+CD25 + regulatory T cells in Heligmosomoides polygyrus infection. Eur. J. Immunol. 37(7), 1874-1886 (2007).
27. 8+ regulatory T cells in the intestine by Heligmosomoides polygyrus infection. Am. J. Physiol. Gastrointest. Liver Physiol. 291(2), G253-G259 (2006).
28. 4+ CD25 + Foxp3 + Treg in mice. Eur. J. Immunol. 39(10), 2822-2830 (2009).
29. Eziefula AC, Brown M. Intestinal nematodes: disease burden, deworming and the potential importance of co-infection. Curr. Opin. Infect. Dis. 21(5), 516-522 (2008).
30. Elias D, Wolday D, Akuffo H et al. Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guerin (BCG) vaccination. Clin. Exp. Immunol. 123(2), 219-225 (2001).
31. Da'dara AA, Harn DA. Elimination of helminth infection restores HIV-1C vaccine-specific T cell responses independent of helminth-induced IL-10. Vaccine 28(5), 1310-1317 (2010).
32. Conteh S, Chattopadhyay R, Anderson C, Hoffman SL. Plasmodium yoelii-infected A. stephensi inefficiently transmit malaria compared to intravenous route. PLoS One 5(1), e8947 (2010).
33. Hoffman SL, Goh LM, Luke TC et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis. 185(8), 1155-1164 (2002).
34. Chattopadhyay R, Conteh S, Li M et al. The effects of radiation on the safety and protective efficacy of an attenuated Plasmodium yoelii sporozoite malaria vaccine. Vaccine 27(27), 3675-3680 (2009).
35. Overstreet MG, Cockburn IA, Chen YC, Zavala F. Protective CD8 T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response. Immunol. Rev. 225, 272-283 (2008).
36. O'Neal SE, Guimaraes LH, Machado PR et al. Influence of helminth infections on the clinical course of and immune response to Leishmania braziliensis cutaneous leishmaniasis. J. Infect. Dis. 195(1), 142-148 (2007).
37. Harris JB, Podolsky MJ, Bhuiyan TR et al. Immunologic responses to Vibrio cholerae in patients co-infected with intestinal parasites in Bangladesh. PLoS Negl. Trop. Dis. 3(3), e403 (2009).
38. Monteiro RV, Dietz JM, Raboy B et al. Parasite community interactions: Trypanosoma cruzi and intestinal helminths infecting wild golden lion tamarins Leontopithecus rosalia and golden-headed lion tamarins L. chrysomelas (Callitrichidae, L., 1766). Parasitol. Res. 101(6), 1689-1698 (2007).
39. Cruz-Chan JV, Quijano-Hernandez I, Ramirez-Sierra MJ, Dumonteil E. Dirofilaria immitis and Trypanosoma cruzi natural co-infection in dogs. Vet. J. DOI:10.1016/j.tvjl.2009.09.012 (2010) (Epub ahead of print).
40. Beadling C, Slifka MK. How do viral infections predispose patients to bacterial infections? Curr. Opin. Infect. Dis. 17(3), 185-191 (2004).
41. Dauby N, Alonso-Vega C, Suarez E et al. Maternal infection with Trypanosoma cruzi and congenital Chagas disease induce a trend to a type 1 polarization of infant immune responses to vaccines. PLoS Negl. Trop. Dis. 3(12), e571 (2009).
42. Elias D, Akuffo H, Pawlowski A et al. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis. Vaccine 23(11), 1326-1334 (2005).
43. Urban JF Jr, Steenhard NR, Solano-Aguilar GI et al. Infection with parasitic nematodes confounds vaccination efficacy. Vet. Parasitol. 148(1), 14-20 (2007).
44. Steenhard NR, Jungersen G, Kokotovic B et al. Ascaris suum infection negatively affects the response to a Mycoplasma hyopneumoniae vaccination and subsequent challenge infection in pigs. Vaccine 27(37), 5161-5169 (2009).
45. Da'Dara AA, Lautsch N, Dudek T et al. Helminth infection suppresses T-cell immune response to HIV-DNA-based vaccine in mice. Vaccine 24(24), 5211-5219 (2006).